THORN RUN PARTNERS for HORIZON THERAPEUTICS USA, INC.
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 22, 2024 | $40,000 | Replaced |
| 1st Quarter - Termination | Jul 15, 2024 | $40,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to orphan drugs and the value of innovative medicines. Legislation supporting the Orphan Drug Act. Issues regarding drug pricing.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | LD - Cong. Tanner, LD - Cong, McIntyre |
Medicare/Medicaid MMM
Issues pertaining to Medicare Part B and Part D. Legislation regarding drug importation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | — |
Taxation/Internal Revenue Code TAX
Issues related to international taxation of corporations.
| Lobbyist | Covered position, as disclosed |
|---|---|
| BEAU SCHUYLER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.